title: Infectious endocarditis due to Corynebacterium xerosis.
abstract: Corynebacterium xerosis is a rare cause of endocarditis, mainly affecting immunocompromised patients and those with predisposing cardiovascular lesions. While often considered a blood culture contaminant, serious infections by this organism have been reported. C. xerosis endocarditis is associated with poor outcomes that could be potentially improved by early recognition and treatment.
authors.affiliation: Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA.
authors.forename: Breno
authors.initials: B
authors.lastname: Pessanha
authors.forename: Andrew
authors.initials: A
authors.lastname: Farb
authors.forename: Thida
authors.initials: T
authors.lastname: Lwin
authors.forename: Bruce
authors.initials: B
authors.lastname: Lloyd
authors.forename: Renu
authors.initials: R
authors.lastname: Virmani
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001021:Aortic Valve / Q000382:microbiology / Q000473:pathology; D001024:Aortic Valve Stenosis / Q000382:microbiology / Q000473:pathology; D002442:Ceftazidime / Q000627:therapeutic use; D003352:Corynebacterium / Q000302:isolation & purification* / Q000472:pathogenicity; D003354:Corynebacterium Infections / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D004452:Echocardiography; D004697:Endocarditis, Bacterial / Q000382:microbiology / Q000473:pathology*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008875:Middle Aged
chemical_list: D000900:Anti-Bacterial Agents; D002442:Ceftazidime